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Summary and Implications
Porcine colonic spirochetosis
(PCS) is a non-fatal, diarrheal disease
affecting pigs during the growing and
finishing stages of production. The
disease is caused by Serpulina pilosicoli,
a newly recognized species of intesti-
nal spirochetes. Because Serpulina
pilosicoli is transmitted by the fecal-
oral route, control measures aimed at
reducing environmental contamination,
including sanitation and antimicro-
bial therapy, should be investigated.
We determined the antimicrobial sus-
ceptibility of seven porcine Serpulina
pilosicoli isolates recovered from pigs
in the midwestern United States against
four antimicrobials commonly used
for control of swine dysentery, a dis-
ease caused by the related spirochete,
Serpulina hyodysenteriae. All the iso-
lates were susceptible to carbadox and
tiamulin, whereas the percentages of
isolates susceptible, intermediate and
resistant were 66.6, 16.6 and 16.6
percent with lincomycin, and 50 per-
cent susceptible and 50 percent resis-
(Continued on next page)
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tant with gentamicin. This informa-
tion is consistent with field observa-
tions about the efficacy of the respec-
tive antimicrobials for control of PCS.
Introduction
Porcine intestinal spirochetes
consist of at least three species in the
genus Serpulina; Serpulina hyodysen-
teriae, the agent of swine dysentery,
Serpulina innocens, a non-pathogenic
spirochete of the swine colon and the
newly recognized Serpulina pilosicoli,
the agent of porcine colonic spiroche-
tosis (PCS). Clinical signs of Serpulina
pilosicoli infection consist of transient-
to-persistent watery to mucoid green
to cement gray cow-manure-like diar-
rhea without blood, usually occurring
10 to 14 days after mixing grower pigs
from different sources. While up to 50
percent of the pigs may show diarrhea,
morbidity varies greatly from farm to
farm and the factors responsible for
this variation are not completely un-
derstood. Although the diarrhea asso-
ciated with PCS usually subsides, the
concurrent depression of weight gains
results in unevenness within affected
groups. This is a major problem in all
in/all out management systems in which
PCS causes disruption of pig flow by
both extending the marketing period
and increasing the number of pigs with
lighter weights.
Because transmission of Serpulina
pilosicoli is by the fecal-oral route,
control measures aimed at reducing
environmental contamination, includ-
ing sanitation and antimicrobial therapy,
should provide adequate disease con-
trol. Since Serpulina pilosicoli is a
newly identified intestinal spirochete,
determining the antimicrobial suscep-
tibility of this organism so disease-
specific control strategies can be imple-
mented is important. In this study, we
determined the antimicrobial suscep-
tibility of seven porcine Serpulina
pilosicoli isolates against four antimi-
crobials commonly used to treat swine
dysentery. The Serpulina pilosicoli were
isolated from pigs on farms in the
midwestern United States.
Materials and Methods
A total of seven isolates of Serpulina
pilosicoli were obtained from rectal
swabs or colonic scrapings taken from
pigs on farms in Iowa (n = 2), Missouri
(n = 3) and Nebraska (n = 1). All the
isolates were from different farms ex-
cept isolates UNL-53 and UNL-54,
which were both obtained from one
farm in Missouri (Table 1). After iso-
lating the spirochetes by anaerobic
culture on selective medium, repre-
sentative isolates were characterized
using a polymerase chain reaction
amplification method specific for
Serpulina pilosicoli. The minimal in-
hibitory concentrations (MIC) of
carbadox, gentamicin, lincomycin and
tiamulin against the Serpulina pilosicoli
isolates were determined by an agar-
dilution method.
Results
The MIC of carbadox, gentami-
cin, lincomycin and tiamulin against
each Serpulina pilosicoli solate is pre-
sented in Table 1. Because isolates
UNL-53 and UNL-54 were obtained
from the same farm and had the same
MIC values, they were considered one
for the calculations of the MIC of each
antimicrobial effective against 50 per-
cent (MIC
50
) and 90 percent (MIC
90
) of
the isolates (Table 2). From available
literature data on the antimicrobial
susceptibility breakpoints of Serpulina
hyodysenteriae for each antimicrobial,
we estimated all of the Serpulina
pilosicoli isolates were susceptible to
carbadox and tiamulin. However, the
percentages of isolates susceptible,
intermediate and resistant were 66.6,
16.6 and 16.6 percent with lincomy-
cin, and 50 percent susceptible and 50
percent resistant with gentamicin.
Discussion
The results from this study indi-
cate the pattern of antimicrobial sus-
ceptibility of midwestern porcine
Serpulina pilosicoli to antimicrobials
used for treatment of swine dysentery
was similar to that of Serpulina
hyodysenteriae. Because of this, con-
trol measures known to be effective for
swine dysentery, including stress re-
duction, sanitation and medication of
Table 2. Minimal inhibitory concentration (MIC) values of four antimicrobials against Serpulina
pilosicoli isolates obtained from pigs on farms in the midwestern United States
Antimicrobial Drug concentration MIC
50
MIC
90
range (µg/ml)
Carbadox <0.0005 - 0.015 <0.0005 0.015
Gentamicin 1.0 - 10.0 1.0 10.0
Lincomycin 12.5 - 75.0 25.0 75.0
Tiamulin 0.05 - 0.50 0.05 0.50
Table 1. Minimal inhibitory concentration values (µg/ml) of four antimicrobials against Serpulina
pilosicoli isolated from pigs on farms in the midwestern United States
Isolate Origin† Carbadox Gentamicin Lincomycin Tiamulin
UNL-5 Iowa <0.0005 1.0 25.0 0.50
B1555a Iowa <0.0005 1.0 12.5 0.05
UNL-53 Missouri 0.015 10.0 75.0 0.10
UNL-54 Missouri 0.015 10.0 75.0 0.10
UNL-55 Missouri 0.005 10.0 25.0 0.05
B359 Missouri <0.0005 1.0 12.5 0.20
UNL-8 Nebraska 0.005 10.0 50.0 0.05
†All isolates are from different farms except for isolates UNL-53 and UNL-54 which are from the same farm.
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water and feed with Serpulina
hyodysenteriae-specific antimicrobials
should be effective against PCS caused
by Serpulina pilosicoli.
Koch’s postulates for Serpulina
pilosicoli have been fulfilled using
gnotobiotic pigs and conventional pigs.
Following initial association with the
cecal and colonic mucus gel, the spiro-
chetes attach to the colonic enterocytes,
residing in the brush border of the
colonic cells where they damage the
microvilli, causing reduced surface area
and perhaps loss of absorptive func-
tion. Clinical signs of absorption fail-
ure or diarrhea may be seen when the
reserve capacity of the large intestine
is compromised sufficiently. With time,
the disease progresses to a stage in
which the balance between infection
and host response determines whether
the pig remains persistently infected
or eliminates the spirochetes. Pigs per-
sistently infected with Serpulina
pilosicoli develop chronic inflamma-
tion of the large intestine. The follow-
ing altered intestinal function is thought
to result in reduced growth rate.
Serpulina pilosicoli can be iso-
lated from the large intestine of chal-
lenge-inoculated pigs for up to six
weeks post-inoculation, even though
diarrhea may have ceased. This sug-
gests transmission of PCS is from shed-
ding of Serpulina pilosicoli in the fe-
ces of persistently infected pigs. Some
pigs infected with Serpulina pilosicoli
may recover naturally without medi-
cation, but they have reduced average
body weight gain when compared with
noninfected control pigs. Carrier-shred-
der pigs are an important reservoir of
Serpulina pilosicoli on infected farms
and the movement of these pigs is the
most likely means of transmission of
Serpulina pilosicoli between farms.
Management systems favoring fecal-
oral recycling, such as open-flush gut-
ters and recycled lagoon water, appear
to promote maintenance and transmis-
sion of PCS. Thus, in all in/all out
multi-site production systems, trans-
mission is most likely from co-min-
gling susceptible and carrier-shredder
pigs or from the contaminated envi-
ronment. In continuous flow produc-
tion systems, spirochetes are most likely
transmitted when younger Serpulina
pilosicoli-naive pigs come into con-
tact with feces of older pigs. The pos-
sibility also exists that hosts other than
pigs, such as dogs, rodents and wild-
life, including birds, act as sources of
PCS infection, emphasizing the need
for biosecurity.
Diarrheal disease and reduced
performance associated with Serpulina
pilosicoli have been reported from all
major swine producing countries in
North America, Europe and Australia.
We estimated a 50 percent prevalence
rate of Serpulina pilosicoli infection
in finisher facilities within a multi-site
production system in the United States;
a finding not unlike the prevalence of
Serpulina hyodysenteriae s veral years
ago, before control measure for this
spirochete became widely available.
The results of antimicrobial sus-
ceptibility of midwestern isolates of
porcine Serpulina pilosicoli suggested
carbadox and tiamulin may be suitable
for control of PCS. Conversely, the
susceptibility of the isolates to linco-
mycin and gentamicin was variable.
Although field information is consis-
tent with these laboratory results, the
applicability of specific antimicrobi-
als in controlled challenge studies would
be helpful in making cost-effective rec-
ommendations for prevention or treat-
ment of PCS. When response to treat-
ment is poor, (I) error in dosage and/or
inadequate delivery of antimicrobials,
(ii ) combination of agents with differ-
ent antimicrobial susceptibility or (iii )
poor control of environmental con-
tamination may be involved. Eradica-
tion of Serpulina pilosicoli with anti-
microbial therapy and sanitation with
or without depopulation is probably
possible, but it might not be cost-effec-
tive. When PCS occurs concurrently
with other cause(s) of diarrhea, such as
viruses, other bacteria, intestinal
parasites or other non-infectious
causes, mortality is high. In these cases,
thorough laboratory diagnostic inves-
tigation is needed in order to achieve
adequate control.
It is known that Serpulina pilosi-
coli has a broader host range than
Serpulina hyodysenteriae. Spiro-
chetes similar to Serpulina pilosicoli
have been seen in the intestines of
humans, non-human primates, dogs,
guinea pigs, opossums, mice and birds
often with clinical signs or lesions
of colonic spirochetosis. Because
Serpulina pilosicoli has been isolated
from humans with lesions similar to
PCS and human Serpulina pilosicoli
can colonize in pigs and produce
colitis, it may be zoonotic and have
public health significance.
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